Form 8-K - Current report:
SEC Accession No. 0001193125-21-356869
Filing Date
2021-12-14
Accepted
2021-12-14 16:52:01
Documents
13
Period of Report
2021-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d246164d8k.htm   iXBRL 8-K 27513
2 EX-99.1 d246164dex991.htm EX-99.1 6282
  Complete submission text file 0001193125-21-356869.txt   159503

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20211209.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20211209_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20211209_pre.xml EX-101.PRE 11416
6 EXTRACTED XBRL INSTANCE DOCUMENT d246164d8k_htm.xml XML 3413
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 211491639
SIC: 2834 Pharmaceutical Preparations